Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
Dr Jeremy Aroles explores the implications of COVID-19 technologies, and proposes three ways to ensure that these powers can't be abused by the Government.
Ann Hemingway, Professor of Public Health at Bournemouth University, Dept Medical Science & Public Health, discusses how Equine Assisted Interventions can enhance mental health and wellbeing.
While diabetes has been declared as a signifier for infection complications, researchers now say that data suggests it is three times as likely these individuals have severe COVID or are hospitalised.
Dr Sylvie Briand, Director, Global Infectious Hazards Preparedness Department at the World Health Organization, explains how COVID-19 is accompanied by fighting an infodemic.
Here, we look into the many ways in which medical and safety technology manufacturer Dräger has been stepping up to help its customers through the COVID-19 crisis.
Open Access Government discovers how Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, is prioritising the recovery of Europe’s cultural sectors as well as Research and Innovation.
Andrea Ammon, Director at the European Centre for Disease Prevention and Control, takes us on a journey from COVID-19 to the future of public health surveillance.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and will be made available as early as next week.
Dr Anas Nader, co-founder and CEO of Patchwork Health, discusses why we must find reliable ways to keep NHS teams safe when they can't work from home during the pandemic.
Chris Wakefield, Vice President of GOJO Industries-Europe Ltd, explores how businesses can navigate the increase in cleaning products on the market and select products that will best meet their needs.
